Pete addressed the Cramer issue at the share holders meeting. He said Mimedx has to be careful with promoting Epifix/Amniofix lest they draw the ire of the FDA. The FDA is stringent on what they can say/marketing of dhacm. There is a new FDA director now and everything is about to change for the better come September. Pete could only say here is our product (dhacm) and allow Cramer to list potential uses. Crazy Obama world.
Can anyone think of a major joint reconstruction and wound care company that would be interested in M&A with Mimedx? Collafix/Amniofix is one more reason. Smith and Nephew?
This is what the new Collafix is all about. Who does not want to resume their activities sooner? It will be the SOC.
If I had to place a bet, I would place it with the CEO. He is putting his own money up for Mimedx. He said a major company will want Mimedx. Mimedx has a couple new products coming out late 2016.
I have no personal experience with it. Omnigraf is a silicone layer with collagen scaffold underneath to lay against the wound. It has no growth factors, has a much lower success rate in DFU closure and their claim is only one application although many required more than one application.
This from Omnigraf company description:
51% of patients treated with Omnigraft had healed
ulcers compared to 32% of patients treated with standard wound care alone. 57 of
92 patients (62%) who received only a single Omnigraft application experienced
healing of their wound.
Some patients whose diabetic foot ulcers were treated with Omnigraft experienced: a
wound infection (23 of 154 patients, 15%); new, worsening, or recurring wounds (22 of
154 patients, 14%); pain around the wound (14 of 154 patients, 9%); an infection beyond
the wound (either cellulitis or osteomyelitis, which occurred in 21 of 154 patients, 14%);
swelling (7 of 154 patients, 5%), nausea (7 of 154 patients, 5%); and/or a worsening
health condition (6 of 154 patients, 4%).
Vague and unimportant. The same was said of Infuse. Infuse forms bone well in the elderly just as Epifix heals DFUs well in the elderly. 92% success rate of DFU healing. Christian, your short selling seems to be working for now. Biotech sector close to 52 week low helps. I will have Henry point you out at the meeting so we can congratulate you.
Different product now with amnion chorian lining and Collafix backing.Strength and accelerated healing. New product should be available this fall after 510? approval.Just another revenue generator.
How bout, the injectable is being used and growing. I am using the injectable, but the company is now focused on Orthoflow for joints and that has been selling well. The injectable for rotator cuffs, plantar fasciitis, tennis elbow, scar injection and wound healing is still alive, but not promoted until BLAs completed. I don't think it is critical like some initially thought since other products have been released. I believe the company did reveal their strategy in the last conference call. Surgical is still a big growth area, but burn centers will be a big push as this area is actually larger than DFU and that has been big for Mimedx and others. Look at the number of products Mimedx has now and there is much more than when the discussions regarding injectable occurred. Then there was Epifix/Amniofix sheets and injectable. Now there are maybe 10-15 with Collafix on the way.
The short seller Halloween Candy 2013 has several aliases and his real name is Christian. He has achieved his goal of insulting and goading people into meaningless dialogue and not discussing pertinent information. Yes Mimedx is just fine with a first quarter distraction from M&A and sales force shuffling. It is quickly being worked out and Q2 will be fine. Revenues will surge second half with changes taking place.
Go back and review his post history and almost every post is bashing Mimedx or attacking me. He is a &@$?
Otto is a primary pumper from Osiris who wandered over to post disingenious information.
Just remember Q2 strong and you will not have any money for long. Now that we know who you are, it will be amusing to watch you squirm like a worm.